Drug Type Small molecule drug |
Synonyms Cmpd 20p, Cmpd20p |
Target |
Action agonists |
Mechanism FXR agonists(Bile acid receptor FXR agonists), TGR5 agonists(G-protein coupled bile acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H32ClN3O3 |
InChIKeyJTGBSPOXKVOUHU-UHFFFAOYSA-N |
CAS Registry2677689-72-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | Japan | 28 Apr 2021 | |
Nonalcoholic Steatohepatitis | Preclinical | Japan | 28 Apr 2021 |